Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 94

Results For "Chief"

2038 News Found

Grace expands CDMO capacity by 25% of South Haven facility in Michigan
News | March 19, 2024

Grace expands CDMO capacity by 25% of South Haven facility in Michigan

Additional capacity broadens Grace’s fine chemical capabilities for API production


AstraZeneca to acquire Amolyt Pharma
News | March 18, 2024

AstraZeneca to acquire Amolyt Pharma

Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition


Indranil Sen, CFO, Biocon resigned
People | March 16, 2024

Indranil Sen, CFO, Biocon resigned

Sen spent a decade with Biocon and held various key roles,


Cureskin secures US$ 20 million in Series B funding
News | March 14, 2024

Cureskin secures US$ 20 million in Series B funding

Cureskin aims to disrupt the large and growing skin and hair care industry in India


Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9
Clinical Trials | March 14, 2024

Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9

Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers


Jubilant Ingrevia partners with O2 Renewable to increase use of green energy
News | March 13, 2024

Jubilant Ingrevia partners with O2 Renewable to increase use of green energy

This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources


Healthcare Triangle appoints Anand Kumar as Interim CEO
People | March 13, 2024

Healthcare Triangle appoints Anand Kumar as Interim CEO

Anand is committed to leading the company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, AI and LLM


European Commission approves Pfizer’s Prevenar 20 to help protect infants and children against pneumococcal disease
Drug Approval | March 13, 2024

European Commission approves Pfizer’s Prevenar 20 to help protect infants and children against pneumococcal disease

PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally


Pfizer announces positive Phase 3 trial of ADCETRIS regimen in patients with DLBCL
Clinical Trials | March 12, 2024

Pfizer announces positive Phase 3 trial of ADCETRIS regimen in patients with DLBCL

Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS